(DECK) - Six analysts have raised their numbers for this year, while five have done so for next year

Deckers has an excellent history of significantly beating earnings estimates. DECK has beaten the consensus estimate in 14 out of the past 15 quarters, with eight of them surprising by more than 40%. Six analysts have raised their numbers for this year, while five have done so for next year. Over the past 60 days, this year's estimates have increased 7.5% to $2.45 per share, while next year's numbers have jumped 6.8% to $2.84 per share. DECK is attractively priced at 15x next year's estimates, in-line with the long-term growth rate of 15%. Full Analysis Deckers Outdoor Corporation (DECK) engages in the design, production, and brand management of footwear for men, women, and children in the United States. Its products include slides, sport sandals, thongs, amphibious footwear, trail running shoes, hiking boots, rugged closed-toe footwear, sheepskin boots and slippers, and other casual footwear. The company provides its products under Teva, Simple, and UGC brand names. Deckers Outdoor offers its products through domestic retailers; international distributors; and through its Web sites, catalogs, and retail outlet stores to end-user consumers. The company also operates in China and Macau. DECK's stock got a strong boost after reporting second-quarter earnings that exceeded estimates and lifting its outlook. The company posted earnings of $2.7 million, or 21 cents per share. Sales edged 3 percent higher to $41.7 million from $40.3 million a year ago. Deckers had expected earnings in a range of 3 cents to 5 cents per share and sales of $38 million to $40 million. Analysts forecast profit and revenue at the high end of the company's projections. The company raised its full-year outlook. Deckers now sees sales of $272 million to $278 million, up from a high-end estimate of $276 million. Earnings should range from $2.39 to $2.45 per share, up from a previous best-case estimate of $2.29. Angel Martinez, President and Chief Executive Officer, stated, "We are very pleased that the positive momentum in our business has continued, allowing us to once again exceed expectations. During the quarter we experienced strong full price selling across all three of our brands evidenced by the 600 basis point improvement in our gross margin. We are particularly encouraged by the performance of Teva, as consumer reaction to a limited introduction of new styles as well as improved retail presence, helped drive results. At the same time, our strategic investments in marketing and advertising, research & development, and our retail and international infrastructures have us well positioned to capitalize on the many opportunities that still lie ahead, both domestically and overseas. We are focused on successfully executing our business plan and are dedicated to driving increased profitability and greater shareholder value." The company has an excellent history of significantly beating earnings estimates. DECK has beaten the consensus estimate in 14 out of the past 15 quarters, with eight of them surprising by more than 40%. Six analysts have raised their numbers for this year, while five have done so for next year. Over the past 60 days, this year's estimates have increased 7.5% to $2.45 per share, while next year's numbers have jumped 6.8% to $2.84 per share. DECK is attractively priced at 15x next year's estimates, in-line with the long-term growth rate of 15%. Note: The Zacks Rank is a very sensitive indicator that can change frequently for an individual stock. This important indicator is updated daily on Zacks.com and is available to Zacks Premium subscribers. As such, it is prudent to check the site for the latest Zacks Rank on the stocks highlighted in this section. Simply click the link for the stock or enter the symbol in the ticker entry box in the upper left hand corner of the web site. Content Courtesy: Zacks Investment Research #1 Ranked Stocks Highlight Archive To truly take advantage of the Zacks Rank, you need to first understand how it works. That is why we created the free special report: Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions. | Blog Home| VitalStocks Home